|
1）Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mid-to-moderate coronary artery disease? Circulation. 1988; 78: 1157-66
|
|
|
|
2）Boden WE, O’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007; 356: 1503-16
|
|
|
|
|
|
3）Stone G, Maehara A, Lansky A, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011; 364: 226-35
|
|
|
|
|
|
4）Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995; 92: 1355-74
|
|
|
|
|
|
5）Narula J, Nakano M, Virmani R, et al. Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. J Am Coll Cardiol. 2013; 61: 1041-51
|
|
|
|
|
|
6）Calvert PA, Obaid DR, O’Sullivan M, et al. Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) study. JACC Cardiolvasc Imaging. 2011; 4: 894–901
|
|
|
|
|
|
7）Cheng JM, Garcia-Garcia HM, de Boer SP, et al. In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study.Eur Heart J. 2014; 35: 639-47
|
|
|
|
|
|
8）Bourantas CV, Garcia-Garcia HM, Farooq V, et al. Clinical and angiographic characteristics of patients likely to have vulnerable plaques: analysis from the PROSPECT study. JACC Cardiovasc Imaging. 2013; 6: 1263-72
|
|
|
|
|
|
9）Sano K, Kawasaki M, Ishihara Y, et al. Assessment of vulnerable plaques causing acute coronary syndrome using integrated backscatter intravascular ultrasound. J Am Coll Cardiol. 2006; 47: 734-41
|
|
|
|
|
|
10）Kataoka Y, Wolski K, Uno K, et al. Spotty calcification as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound. J Am Coll Cardiol. 2012; 59: 1592-7
|
|
|
|
|
|
11）Uemura S, Ishigami K, Soeda T, et al. Thin-cap fibroatheroma and microchannel findings in optical coherence tomography correlate with subsequent progression of coronary atheromatous plaques. Eur Heart J. 2012; 33: 78-85
|
|
|
|
|
|
12）Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003; 108: 1664-72
|
|
|
|
|
|
13）Jia H, Abtahian F, Aguirre AD, et al. In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol. 2013; 62: 1748-58
|
|
|
|
|
|
14）Mizukoshi M, Kubo T, Takarada S,et al. Coronary superficial and spotty calcium deposits in culprit coronary lesions of acute coronary syndrome as determined by optical coherence tomography.Am J Cardiol. 2013; 112: 34-40
|
|
|
|
|
|
15）Virmani R, Burke AP, Farb A, et al. Pathology of vulnerable plaque. J Am Coll Cardiol. 2006; 47: C13-8
|
|
|
|
|
|
16）Vergallo R, Ren X, Yonetsu T, et al. Pancoronary plaque vulnerability in patients with acute coronary syndrome and ruptured culprit plaque: a 3-vessel optical coherence tomography study. Am Heart J. 2014; 167: 59-67
|
|
|
|
|
|
17）Tian J, Ren X, Vergallo R,et al. Distinct morphological features of ruptured culprit plaque for acute coronary events compared to those with silent rupture and thin-cap fibroatheroma: a combined optical coherence tomography and intravascular ultrasound study. J Am Coll Cardiol. 2014; 63: 2209-16
|
|
|
|
|
|
18）Shimamura K, Ino Y, Kubo T, et al. Difference of ruptured plaque morphology between asymptomatic coronary artery disease and non-ST elevation acute coronary syndrome patients: An optical coherence tomography study. Atherosclerosis. 2014; 235: 532-7
|
|
|
|
|
|
19）Ueda Y, Ohtani T, Shimizu M, et al. Assessment of plaque vulnerability by angioscopic classification of plaque color. Am Heart J. 2004; 148: 333-5
|
|
|
|
|
|
20）Ohtani T, Ueda Y, Mizote I, et al. Number of yellow plaque detected in a coronary artery is associated with future risk of acute coronary syndrome: Detection of vulnerable patients by angioscopy. J Am Coll Cardiol. 2006; 47: 2194-200
|
|
|
|
|
|
21）Kashiwagi M, Tanaka A, Kitabata H, et al. Feasibility of noninvasive assessment of thin-cap fibroatheroma by multidetector computed tomography. JACC Cardiovasc Imaging. 2009; 2: 1412-9
|
|
|
|
|
|
22）Maurovich-Horvat P, Schlett CL, Alkadhi H, et al. The napkin-ring sign indicates advanced atherosclerotic lesions in coronary CT angiography. JACC Cardiovasc Imaging. 2012; 5: 1243-52
|
|
|
|
|
|
23）Otsuka K, Fukuda S, Tanaka A, et al. Napkin-ring sign on coronary CT angiography for the prediction of acute coronary syndrome. JACC Cardiovasc Imaging. 2013; 6: 448-57
|
|
|
|
|
|
24）Motoyama S, Sarai M, Harigaya H, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol. 2009; 54: 49-57
|
|
|
|
|
|
25）Inoue K, Motoyama S, Sarai M, et al. Serial coronary CT angiography-verified changes in plaque characteristics as an end point: evaluation of effect of statin intervention. JACC Cardiovasc Imaging. 2010; 3: 691-8
|
|
|
|
|
|
26）Zeb I, Li D, Nasir K, et al. Effect of statin treatment on coronary plaque progression-A serial coronary CT angiography study. Atherosclerosis. 2013; 231: 198-204
|
|
|
|
|
|
27）Karolyi M, Seifarth H, Liew G, et al. Classification of coronary atherosclerotic plaques ex vivo with T1, T2, and ultrashort echo time CMR. JACC Cardiovasc Imaging. 2013; 6: 466-74
|
|
|
|
|
|
28）Kawasaki T, Koga S, Koga N, et al. Characterization of hyperintense plaque with noncontrast T1-weighted cardiac magnetic resonance coronary plaque imaging: comparison with multislice computed tomography and intravascular ultrasound. JACC Cardiovasc Imaging. 2009; 2: 720-8
|
|
|
|
|
|
29）Noguchi T, Kawasaki T, Tanaka A, et al. High-intensity signals in coronary plaques on noncontrast T1-weighted magnetic resonance imaging as a novel determinant of coronary event. J Am Coll Cardiol. 2014; 63: 989-99
|
|
|
|
|
|
30）Hattori K, Ozaki Y, Ismail TF, et al. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS. JACC Cardiovasc Imaging. 2012; 5: 169-77
|
|
|
|
|
|
31）Nishio R, Shinke T, Otake H, et al. Stabilizing effect of combined eicosapentaenoic acid and statin therapy on coronary thin-cap fibroatheroma. Atherosclerosis. 2014; 234: 114-9
|
|
|
|
|
|
32）Urban D, Poss J, Bohm M, et al. Targeting the proprotein convertase subtilisin/kexin type 9 (PCSK9) for the treatment of dyslipidemia and atherosclerosis. J Am Coll Cardiol. 2013; 62: 1401-8
|
|
|
|
|
|
33）Blom DJ, Hala T, Bolognese M, et al. A 52-week placebo-controlled trial of evolocumab in hyperlipidemia. N Engl J Med. 2014; 370: 1809-19
|
|
|
|
|
|
34）Sullivan D, Olsson AG, Scott R, et al. Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin intolerant patients: the GAUSS randomized trial. JAMA. 2012; 308: 2497-506
|
|
|
|
|
|
35）Kolodgie FD, Burke AP, Skorija KS, et al. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2006; 26: 2523-9
|
|
|
|
|
|
36）STABILITY Investigators, White HD, Held C, et al. Darapladib for preventing ischemic events in stable coronary heart disease. N Engl J Med. 2014; 370: 1702-11
|
|
|
|
|
|
37）Wyrzykowska JJ, Diletti R, Gutierrez-Chico JL, et al. Plaque sealing and passivation with a mechanical self-expanding low outward force nitinol vShield device for the treatment of IVUS and OCT-derived thin cap fibroatheromas (TCFAs) in native coronary arteries: report of the pilot study vShield Evaluated at Cardiac hospital in Rotterdam for Investigation and Treatment of TCFA (SECRITT). EuroIntervention. 2012; 8: 945-54
|
|
|
|
|
|
38）Stone GW. Bioresorbable vascular scaffolds: is imaging everything? EuroIntervention. 2014; 9: 1255-7
|
|
|
|
|